StreetInsider.com News Articles

Davion Healthcare appoints new CFO and non-executive director

Tue, 02 Dec 2025 11:23:42 -0400

Davion Healthcare Plc announced the appointment of Andreas Ttofi as Chief Financial Officer and Jan Dulman as Independent Non-Executive Director and Chair of the Audit Committee, both effective immediately.

Ttofi is an ACCA Member with over a decade of experience in audit, financial reporting, taxation, and operational finance. Since 2012, he has advised corporate and private clients across multiple sectors, according to the company statement.

Dulman is a Certified Public Accountant with experience as a CFO, audit professional, and senior accounting partner. He previously served as Controller and CFO of a publicly listed mining exploration company and founded a CPA partnership that

Davion Healthcare appoints new CFO and non-executive director

Tue, 02 Dec 2025 11:23:42 -0400

Davion Healthcare Plc Announces Appointment of New Chief Financial Officer and Independent Non-Executive Director

Tue, 02 Dec 2025 11:23:00 -0400

New York, Dec. 2, 2025 /PRNewswire/ -- Davion Healthcare Plc ("Davion" or the "Company"), the medical technology company advancing non-invasive home tests for various medical anomalies including cancer, today announced the appointment of Mr. Andreas Ttofi as Chief Financial Officer and Mr. Jan Dulman, CPA, as Independent Non-Executive Director and Chair of the Audit Committee, both effective immediately.

Andreas Ttofi – Chief Financial Officer

Mr. Ttofi is a fully qualified ACCA Member and accomplished accountant with over a decade of professional experience in audit, financial reporting, taxation, and operational finance. Since 2012, he has advised a

Davion Healthcare Plc Announces Appointment of New Chief Financial Officer and Independent Non-Executive Director

Tue, 02 Dec 2025 11:23:00 -0400

Andreas Ttofi – Chief Financial Officer

Davion Healthcare Plc Announces Appointment of New Chief Financial Officer and Independent Non-Executive Director

Tue, 02 Dec 2025 11:23:00 -0400

Andreas Ttofi – Chief Financial Officer

Davion Healthcare Plc Announces Appointment of New Chief Financial Officer and Independent Non-Executive Director

Tue, 02 Dec 2025 11:23:00 -0400

Andreas Ttofi – Chief Financial Officer

Davion Healthcare's F-1 registration statement becomes effective

Fri, 28 Nov 2025 10:00:34 -0400

Davion Healthcare Plc (NASDAQ: DAVI) announced that its Registration Statement on Form F-1, filed with the U.S. Securities and Exchange Commission on November 7, 2025, has become automatically effective under Section 8(a) of the Securities Act of 1933.

The medical technology company also filed a Form 8-A to register its ordinary shares under Section 12(b) of the Securities Exchange Act of 1934 in connection with the F-1's effectiveness.

Davion stated it is completing remaining administrative steps with The Nasdaq Stock Market regarding admission of its ordinary shares for trading. The company said it will make a further announcement once it receives confirmation

Davion Healthcare's F-1 registration statement becomes effective

Fri, 28 Nov 2025 10:00:34 -0400

The medical technology company also filed a Form 8-A to register its ordinary shares under Section 12(b) of the Securities Exchange Act of 1934 in connection with the F-1's effectiveness.

DAVION HEALTHCARE PLC FORM F-1 BECOMES AUTOMATICALLY EFFECTIVE UNDER SECTION 8(a)

Fri, 28 Nov 2025 10:00:00 -0400

NEW YORK, Nov. 28, 2025 /PRNewswire/ -- Davion Healthcare Plc ("Davion" or the "Company"), the medical technology company developing non-invasive home tests for early-stage identification of various medical anomalies including cancer, today announced that its Registration Statement on Form F-1, filed with the U.S. Securities and Exchange Commission on November 7, 2025, has become automatically effective in accordance with Section 8(a) of the Securities Act of 1933.

In connection with the effectiveness of the Form F-1, Davion has also filed a Form 8-A to register its ordinary shares under Section 12(b) of the Securities Exchange

DAVION HEALTHCARE PLC FORM F-1 BECOMES AUTOMATICALLY EFFECTIVE UNDER SECTION 8(a)

Fri, 28 Nov 2025 10:00:00 -0400

In connection with the effectiveness of the Form F-1, Davion has also filed a Form 8-A to register its ordinary shares under Section 12(b) of the Securities Exchange

Davion Healthcare files for direct NASDAQ listing under ticker DAVI

Mon, 04 Aug 2025 12:19:04 -0400

Davion Healthcare Plc filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission for a proposed direct listing of its ordinary shares on the NASDAQ Global Market under the ticker symbol "DAVI."

The Irish-registered company, which specializes in non-invasive medical technologies, is not conducting an initial public offering and will not raise new capital through this listing. The registration statement covers only existing ordinary shares held by current shareholders.

The registration statement has been filed with the SEC but has not yet become effective. The company's ordinary shares cannot be sold until the registration statement becomes effective.

The information

Davion Healthcare files for direct NASDAQ listing under ticker DAVI

Mon, 04 Aug 2025 12:19:04 -0400

The registration statement has been filed with the SEC but has not yet become effective. The company's ordinary shares cannot be sold until the registration statement becomes effective.

The information